thyroxine has been researched along with Cafe-au-Lait Spots with Pulmonic Stenosis in 2 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neurofibromatosis type 1 is an autosomal dominant neurocutaneous disorder in which the coexistence of autoimmune thyroiditis and thyroid gland tumours has been reported previously." | 1.46 | Endocrinological Evaluations of a Neurofibromatosis Type 1 Cohort: Is it Necessary to Evaluate Autoimmune Thyroiditis in Neurofibromatosis Type 1? ( Güler, S; Önal, H; Yeşil, G, 2017) |
| "Myxedema coma, a rare but fatal emergency, is an extreme expression of hypothyroidism." | 1.39 | [Myxedema coma in a patient with type 1 neurofibromatosis: rare association]. ( Lalli, CA; Sasazawa, DT; Tsukumo, DM, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Güler, S | 1 |
| Yeşil, G | 1 |
| Önal, H | 1 |
| Sasazawa, DT | 1 |
| Tsukumo, DM | 1 |
| Lalli, CA | 1 |
2 other studies available for thyroxine and Cafe-au-Lait Spots with Pulmonic Stenosis
| Article | Year |
|---|---|
Endocrinological Evaluations of a Neurofibromatosis Type 1 Cohort: Is it Necessary to Evaluate Autoimmune Thyroiditis in Neurofibromatosis Type 1?
Topics: Autoantibodies; Biomarkers; Case-Control Studies; Child; Female; Humans; Male; Neurofibromatosis 1; | 2017 |
[Myxedema coma in a patient with type 1 neurofibromatosis: rare association].
Topics: Coma; Humans; Male; Middle Aged; Myxedema; Neurofibromatosis 1; Thyroxine; Treatment Outcome | 2013 |